Enlivex Ltd.
ENLV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596812
No open-market purchases or sales by Enlivex Ltd. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $2.34M in total; ARK Invest is the only superinvestor holding it.
Holders of 5% or more of ENLV
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Enlivex Ltd., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Lind Partners LLC | 13G | 9.99%1.93M shares | New | Aug 13, 20261 filing | Aug 13, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Enlivex Ltd., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 13, 20264:04 PM ET | Lind Partners LLCand 2 others | 13G | 9.99%1.93M shares | New | Aug 11, 2026 | SEC |
| Aug 14, 20258:46 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%1.18M shares | −2.54 ppfrom 7.53%Below 5% | Jun 30, 2025 | SEC |
| May 15, 20253:27 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 7.53%1.78M shares | −2.22 ppfrom 9.75% | Mar 31, 2025 | SEC |
| Feb 14, 20255:43 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.75%2.21M shares | – | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Armistice Capital, LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Enlivex Ltd. shares.
No Form 144 notices for Enlivex Ltd. are on file.